OverviewChartNewsTraderScreen

Evoke PLC/  GI000A0F6407  /

Cboe Europe BXE
8/1/2024  5:29:52 PM Chg. -1.05 Volume Bid5:30:00 PM Ask5:30:00 PM High Low
58.00GBX -1.78% 114,476
Turnover(GBP): 66,521.2878		 -Bid Size: - -Ask Size: - 59.10 57.30
Newsfile Corp 7/25 Transform Your Leadership: Gregory H. Garrison Releases Groundbreaking Books "LEAD! Book 1" and "LEA...
GlobeNewswire 6/26 Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire 6/26 Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt
GlobeNewswire 6/26 Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire 6/25 MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
GlobeNewswire 6/24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 6/23 Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentati...
GlobeNewswire 6/22 Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presen...
GlobeNewswire 6/20 Inspired Entertainment and William Hill Extend Long-Term Partnership
GlobeNewswire 6/20 Altimmune to Participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day to Discuss ADA...
GlobeNewswire 6/18 4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire 6/18 Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low ...
GlobeNewswire 6/18 Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes As...
GlobeNewswire 6/17 Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
GlobeNewswire 6/12 Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Host...
GlobeNewswire 6/12 Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Heal...
GlobeNewswire 6/8 4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire 6/7 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 6/6 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire 6/5 Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying ...
GlobeNewswire 6/4 4DMT Announces Presentations at Clinical Trials at the Summit 2024 Meeting
GlobeNewswire 6/3 4DMT to Participate in Upcoming Investor Conferences
GlobeNewswire 5/30 4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire 5/29 Altimmune to Participate at Two Upcoming Investor Conferences
GlobeNewswire 5/29 Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2...